LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Multiplex Nested PCR Detects Bloodstream Candida Species

By LabMedica International staff writers
Posted on 14 Aug 2014
Print article
Image: The Veriti 96-Well Thermal Cycler for polymerase chain reactions (PCR) (Photo courtesy of Applied Biosystems).
Image: The Veriti 96-Well Thermal Cycler for polymerase chain reactions (PCR) (Photo courtesy of Applied Biosystems).
Image: Candida tropicalis growing on specific CHROMagar culture media (Photo courtesy of Takamasa Kaneko).
Image: Candida tropicalis growing on specific CHROMagar culture media (Photo courtesy of Takamasa Kaneko).
A multiplex nested polymerase chain reaction (PCR) method has been developed to detect and identify seven Candida species in peripheral blood samples of critically ill pediatric patients.

Nosocomial candidaemia is associated with high mortality rates in critically ill pediatric and neonatal patients and therefore the early detection and identification of the infectious fungal agent is crucial for successful medical intervention.

Clinical microbiologists at the University of Sao Paulo (Butanta, Brazil) enrolled 54 consecutive pediatric patients, among whom there were 24 neonates, admitted to the intensive care unit (ICU) of two pediatric referral hospitals in Sao Paulo State (Brazil). The patients presented with systemic inflammatory response syndrome (SIRS) and at least two predisposing conditions/risk factors for the development of candidaemia. A control group included 28 children that had no evidence of any type of bloodstream infection and had undergone minor surgical procedures during the same time.

Blood samples were taken and either cultured or had DNA extracted. The 54 DNA samples were evaluated by multiplex nested PCR with specific primers designed to identify seven Candida species, and the results were compared with those obtained from blood cultures.

The extracted DNA samples were amplified and the reactions were carried out in a Veriti thermocycler (Applied Biosystems; Carlsbad, CA, USA). The nested PCR products were detected on 2.5% agarose gels and visualized under a UV transilluminator apparatus (UVITEC; Cambridge, UK).

The multiplex nested PCR had a detection limit of four Candida genomes/mL of blood for all Candida species. Blood cultures were positive in 14.8% of patients, whereas the multiplex nested PCR was positive in 24.0% of patients, including all culture-positive patients. The results obtained with the molecular technique were available within 24 hours, and the assay was able to identify Candida species with 100% of concordance with blood cultures. Additionally the multiplex nested PCR detected dual candidaemia in three patients. Candida albicans was the most frequently isolated species in blood cultures (five out of eight positive results), while the multiplex nested PCR identified C. albicans, C. parapsilosis complex, and C. tropicalis at similar frequencies.

The authors concluded that multiplex PCR assay targeting the intergenic space region (ITS) of Candida ribosomal DNA was able to identify the main Candida species involved in bloodstream pediatric infections with a detection limit of less than 10 colony forming units (CFU)/mL. The assay had high specificity, and is as least as sensitive as blood cultures but with a shorter turnaround time. The use of the multiplex nested PCR method also allowed the detection and identification of one or more Candida species in the same reaction. The study was published on July 21, 2014, in the journal BMC Infectious Diseases.

Related Links:
University of Sao Paulo
Applied Biosystems
UVITEC


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Lyme Disease Test
Lyme IgG/IgM Rapid Test Cassette
New
Malaria Test
STANDARD Q Malaria P.f/Pan Ag

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.